3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
5
Prostatic Neoplasms
3
Smoking Cessation
2
Neoplasm Metastasis
2
Lymphoma
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Retroviridae Infections
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Multiple Myeloma
1
Motor Activity
1
Leukemia
1
Inflammation
1
Glioblastoma
1
Esophageal Neoplasms
1
Dyspnea
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Interventions
Oxaliplatin
64
pembrolizumab
48
Fluorouracil
44
Capecitabine
38
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
19
Docetaxel
18
Cisplatin
18
S 1 (combination)
16
Bevacizumab
15
Ramucirumab
13
Irinotecan
13
Drug Therapy
13
tislelizumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
sintilimab
8
Specimen Handling
8
Biopsy
8
atezolizumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
durvalumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Hematologic Tests
×
1 year
×
Clear all
NCT06346054
2026-02-17
MAGEC
KU Leuven
Phase NA
Recruiting
1,000 enrolled